Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boston Scientific Gulps Down Claret After Cryterion, In Double-Whammy July

Executive Summary

Boston Scientific has inked a deal of up to $270m for embolic protection system developer Claret Medical, marking its second acquisition in the space of two weeks.


Related Content

M&A Analysis: Big Medtechs Relentless On Acquisition Path As July Activity Heats Up
Three Devices Gain Medicare Add-Ons, Including Boston Sci's New TAVR Protector
ReCor Deal Underscores RDN Revival – But Also Reason For Backing Medtech?
LOTUS Wilts? Analysts Pessimistic Over Further Delays in Boston Scientific's TAVR Return
Boston Scientific Adds Single-Shot AF-Ablation Balloon With Apama Acquisition
FDA Go-Ahead For Sentinel TAVR Filter Could Drive Procedure Volumes, Firm Says
Symetis TAVR Buy Not About Throwing Shade On Lotus, BSX Insists


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts